N

Nanoform Finland Oyj
OMXH:NANOFH

Watchlist Manager
Nanoform Finland Oyj
OMXH:NANOFH
Watchlist
Price: 1.23 EUR 1.49% Market Closed
Market Cap: 105.2m EUR
Have any thoughts about
Nanoform Finland Oyj?
Write Note

Relative Value

The Relative Value of one NANOFH stock under the Base Case scenario is 0.74 EUR. Compared to the current market price of 1.23 EUR, Nanoform Finland Oyj is Overvalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NANOFH Relative Value
Base Case
0.74 EUR
Overvaluation 40%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
6
Median 3Y
67.1
Median 5Y
70.3
Industry
4.1
Forward
20.1
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-12.1
Industry
32.7
Forward
-4.6
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-14.7
Industry
22.1
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-9.7
Industry
33.6
vs History
96
vs Industry
41
Median 3Y
2.5
Median 5Y
2.9
Industry
2.6
vs History
83
vs Industry
7
Median 3Y
48.7
Median 5Y
51.4
Industry
3.9
Forward
12.5
vs History
vs Industry
Median 3Y
-11.8
Median 5Y
-16
Industry
8.6
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-10
Industry
18.5
Forward
-3
vs History
vs Industry
Median 3Y
-6
Median 5Y
-8.9
Industry
23.7
Forward
-2.6
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-11.1
Industry
21.4
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-7.8
Industry
28.8
vs History
96
vs Industry
23
Median 3Y
4.6
Median 5Y
6.4
Industry
2.4

Multiples Across Competitors

NANOFH Competitors Multiples
Nanoform Finland Oyj Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FI
Nanoform Finland Oyj
OMXH:NANOFH
96.5m EUR 39.8 -4.2 -2.9 -2.5
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 450.7 4 823 1 522 3 243.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.9B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.5B USD 7.8 42.5 26.7 40.2
KR
Samsung Biologics Co Ltd
KRX:207940
67.5T KRW 15.5 64.2 34.7 50
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.4B USD 5.9 29.8 22.2 25.9
US
IQVIA Holdings Inc
NYSE:IQV
36.2B USD 2.4 25.7 14.2 21.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.6 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
23.9B USD 8.3 47.8 32.1 40.3
CN
WuXi AppTec Co Ltd
SSE:603259
163.8B CNY 4.3 20.3 14.8 14.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FI
N
Nanoform Finland Oyj
OMXH:NANOFH
Average EV/EBITDA: 175.7
Negative Multiple: -2.9
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 522
23%
66.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.2
19%
1.1
US
Danaher Corp
NYSE:DHR
26.7
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.7
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.2
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.2
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.1
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.1
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
52%
0.3

See Also

Discover More
Back to Top